Literature DB >> 29449059

Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanoma.

Pauline Tétu1, Joanna Mangana2, Reinhard Dummer2, Caroline Dutriaux3, Nathalie Beneton4, Stéphane Dalle5, Nicolas Meyer6, Bastien Oriano7, Olivier Michielin8, Céleste Lebbe9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29449059     DOI： 10.1016/j.ejca.2018.01.062

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma.

Authors:  Lisa Haas; Anais Elewaut; Camille L Gerard; Christian Umkehrer; Lukas Leiendecker; Malin Pedersen; Izabela Krecioch; David Hoffmann; Maria Novatchkova; Mario Kuttke; Tobias Neumann; Ines Pires da Silva; Harriet Witthock; Michel A Cuendet; Sebastian Carotta; Kevin J Harrington; Johannes Zuber; Richard A Scolyer; Georgina V Long; James S Wilmott; Olivier Michielin; Sakari Vanharanta; Thomas Wiesner; Anna C Obenauf
Journal:  Nat Cancer       Date:  2021-07-15

2.  Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy.

Authors:  Yujue Wang; Sixue Liu; Zhentao Yang; Alain P Algazi; Shirley H Lomeli; Yan Wang; Megan Othus; Aayoung Hong; Xiaoyan Wang; Chris E Randolph; Alexis M Jones; Marcus W Bosenberg; Stephanie D Byrum; Alan J Tackett; Henry Lopez; Clayton Yates; David B Solit; Antoni Ribas; Marco Piva; Gatien Moriceau; Roger S Lo
Journal:  Cancer Cell       Date:  2021-08-19       Impact factor: 38.585

Review 3.  Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue.

Authors:  Rossella Loria; Patrizia Vici; Francesca Sofia Di Lisa; Silvia Soddu; Marcello Maugeri-Saccà; Giulia Bon
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

4.  Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases.

Authors:  Justin T Moyers; Esther G Chong; Jiahao Peng; Hsin Hsiang Clarence Tsai; Daniel Sufficool; David Shavlik; Gayathri Nagaraj
Journal:  Cancer Med       Date:  2021-01-22       Impact factor: 4.452
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.